Searchable abstracts of presentations at key conferences in endocrinology

ea0077oc2.1 | Endocrine Cancer and Late Effects | SFEBES2021

Outcomes of surgery and treatment with selective RET TK inhibitor Selpercatinib in children with MEN2 and advanced MTC.

Kurzawinski Tom , Hubbard Jonathan , Abdel Aziz Tarek , Butler Colin , Brain Caroline , Beale Tim , Gaze Mark , Ross Emma , Stoneham Sarah , Hulse Tony , Simpson Kate , Proctor Ian , Cattaneo Elene , Gevers Evelien , Marshall Lynley , Shankar Ananth

Background: Patients with Multiple Endocrine Neoplasia type 2 (MEN2) without previous family history often present late with advanced Medullary Thyroid Cancer (MTC). Surgery is not always curative but RET tyrosine kinase pathway is a potential target for molecular treatment for progressive MTC.Methods: Retrospective review of clinical, genetic, biochemical (calcitonin, CEA) and imaging (US, CT/MRI, Gallium Dotate) data of children with MEN2 who developed...